Screener
Sunshine Biopharma SBFM Q2 2025 earnings
Reported August 12, 2025 · Before market open
Revenue$9.4MMiss by $1.7M
EPS-$0.39Miss by $0.28
Revenue estimate$11.1M
EPS estimate-$0.11
Next report
Nov 12, 2026 (in a month)Revenue estimate$9.6M
EPS estimate-$0.17
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Sunshine Biopharma report Q2 2025 earnings?
- Sunshine Biopharma (SBFM) reported Q2 2025 earnings on August 12, 2025 before market open.
- What were Sunshine Biopharma's Q2 2025 revenue and EPS?
- Sunshine Biopharma reported revenue of $9.4M and eps of $-0.39 for Q2 2025.
- Did Sunshine Biopharma beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $11.1M by $1.7M. EPS missed the consensus estimate of $-0.11 by $0.28.
- How did Sunshine Biopharma's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 1.2% from $9.3M a year earlier and eps grew 96.1% from $-9.94.
- Where can I find Sunshine Biopharma's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001683168-25-005981) directly on SEC EDGAR. The filing index links above go to sec.gov.
